Back
Sarepta Therapeutics Stock Predictions

20-cent Gold Stock Has Backing of Major Gold Producers
The time to get in is now BEFORE next drill results are released.
Sell
47
SRPT
Sarepta Therapeutics
Last Price:
130.97
Seasonality Move:
15.81%
7 Day Trial
ALL ACCESS PASS
$
7

Get Free, Instant Access To Today's Top Stocks List!
View this list for FREE now!Sarepta Therapeutics Stock Forecast
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 41.6% based on the past 25 years of stock performance.
- Sarepta Therapeutics has risen higher in 13 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 52%
-
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 41.6% based on the past 25 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
47
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
- Sarepta Therapeutics has risen higher in 13 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 52%
Sarepta Therapeutics Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
159.84
52-Week Low:
61.28
Prediction Charts
Market Cap:
11.45B
Price in USD:
130.19
Volume:
969.14K
Beta:
1.04
Technical Analysis
SMA50:
130.33
SMA100:
124.22
SMA200:
111.00
52-Wk Change:
61.85%
Stock Predictions
-
Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company. -
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 130.19 USD today. -
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-7 | 156.66 | 155.61 | 158.20 | 154.55 |
Mar-8 | 155.36 | 152.96 | 155.87 | 151.42 |
Mar-9 | 152.35 | 148.44 | 153.79 | 146.86 |
Mar-10 | 148.45 | 143.92 | 148.50 | 141.00 |
Mar-13 | 143.04 | 142.77 | 149.00 | 142.21 |
Mar-14 | 143.81 | 144.90 | 148.26 | 143.73 |
Mar-15 | 143.84 | 145.47 | 145.81 | 142.86 |
Mar-16 | 145.51 | 149.67 | 150.81 | 143.75 |
Mar-17 | 119.31 | 122.69 | 125.08 | 117.11 |
Mar-20 | 123.89 | 131.38 | 131.77 | 123.30 |
Mar-21 | 132.68 | 131.17 | 137.09 | 130.45 |
Mar-22 | 131.94 | 128.86 | 131.94 | 128.71 |
Mar-23 | 130.20 | 128.38 | 131.12 | 125.67 |
Mar-24 | 128.97 | 130.19 | 130.54 | 126.99 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.47 per share, and an increase next year of $9.40 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.